Orbita was founded by William A. Rogers, Nathan Treloar in 2015.

Who are Orbita's investors?

Orbita's investors include HealthX Ventures, Marram Ventures, Cultivation Capital, Newark Venture Partners.

How much funding has Orbita raised?

Orbita has disclosed $12.3M raised across 2 rounds.

Where is Orbita headquartered?

Orbita is headquartered in Boston, US.

Orbita

Boston, US · Founded 2015 · Delaware corporation · 67 employees on LinkedIn · 4 known investors

Find your way into Orbita

Paths you didn't know you had: your email and LinkedIn already hold routes to the Orbita team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Orbita provides AI-driven patient engagement and communication software that automates workflows across the care journey, including scheduling, intake, procedure prep, and follow-up. It serves healthcare organizations, aiming to increase patient engagement and reduce staff workload.

AI & Machine Learning Digital Health Healthtech

Founders & leadership

Orbita was founded in 2015 by William A. Rogers and Nathan Treloar.

William A. RogersCo-founder

Nathan Treloar Co-founder · PresidentNathan Treloar is co-founder and president of Orbita, a healthcare software company building AI-driven patient engagement and communication tools. He has experience in conversational AI, enterprise software, product management, and technical sales.

Board

Taha JangelaBoard director

Investors · 4

HealthX Ventureslisted by HealthX VenturesMadisonvia Taha Jangda · quoted

How we know: HealthX Ventures's portfolio page · a partner's Signal profile · board seat on SEC Form D · offering press articles · the VCSheet dataset · Not right? Tell us

Marram Ventureslisted by Marram VenturesSaugatuck · $3M

How we know: Marram Ventures's portfolio page · Not right? Tell us

Cultivation CapitalreportedSt. Louis · $100K – $3.5M

How we know: offering press articles · the VCSheet dataset · Not right? Tell us

Newark Venture PartnersreportedNewark · $100K – $2M

How we know: offering press articles · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$12.3M disclosed across 2 rounds · 2018–2020

▶$6.5MraisedMay 2020 · 8 investors · Other

Rule 506(b)

Orbita Raises $9M for Conversational AI Solutions in Healthcareprnewswire.com · May 2020 · press release

Officers, directors & promoters on the filing

William RogersExecutive Officer, Director
Taha JangdaDirector
Nathan TreloarExecutive Officer

Offering amount: $8.5M
Amount sold: $6.5M
First sale: May 2020
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$5.8MraisedAug 2018 · 18 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Taha JangelaDirector
William A. RogersExecutive Officer, Director
Nathan TreloarExecutive Officer

Offering amount: $7.3M
Amount sold: $5.8M
First sale: Jul 2018
Incorporated: Corporation, Delaware, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 5

Avita MedicalRECELL is an FDA-approved autologous skin cell suspension device for treating burns, trauma, and surgical wounds by harvesting a patient's own skin cells and applying them to accelerate healing and reduce the need for large skin grafts. The technology serves hospital systems and wound care clinicians treating severe burn and trauma patients.

Carbon HealthCarbon Health operates a chain of clinics offering urgent care, primary care, and chronic condition management, combining technology with in-person care to provide broader access to health services. It serves patients seeking everyday healthcare across acute, primary, and chronic needs.

AiVita BiomedicalAIVITA Biomedical is a biotechnology company developing personalized vaccines using an autologous cell therapy platform, including a pan-antigenic cancer vaccine that targets all neoantigens and a multi-pathogen vaccine kit for infectious disease prevention. Its work draws on expertise in stem cell growth and high-purity cell differentiation.

AVIAAVIA operates a network and advisory platform for health systems, providing benchmarking, market intelligence, and peer collaboration to support their digital transformation and AI adoption. It serves hospitals and health systems and includes offerings like AVIA Marketplace and Panda Health for evaluating digital health companies.

GlobaldataGlobalData provides an AI-powered intelligence platform that delivers research, market analysis, and predictive insights to enterprises across industries. The platform combines proprietary data, in-house subject matter experts, and AI tools to support critical business decisions.

Companies working in the same space as Orbita.

In the news

Orbita Raises $9M for Conversational AI Solutions in Healthcareprnewswire.com · May 2020 · press release

Frequently asked questions

What does Orbita do?: Orbita provides AI-driven patient engagement and communication software that automates workflows across the care journey, including scheduling, intake, procedure prep, and follow-up. It serves healthcare organizations, aiming to increase patient engagement and reduce staff workload.
Who founded Orbita?: Orbita was founded by William A. Rogers, Nathan Treloar in 2015.
Who are Orbita's investors?: Orbita's investors include HealthX Ventures, Marram Ventures, Cultivation Capital, Newark Venture Partners.
How much funding has Orbita raised?: Orbita has disclosed $12.3M raised across 2 rounds.
Where is Orbita headquartered?: Orbita is headquartered in Boston, US.